IDEV Technologies, a provider of minimally invasive medical technologies, has performed the first procedure in the US utiliSing the Supera Veritas Transhepatic Biliary System, which was recently cleared to market by the US Food and Drug Administration.
IDEV said that the Supera wire interwoven nitinol stent is currently cleared in the US for palliative treatment of biliary strictures produced by malignant neoplasms.
The Supera Veritas transhepatic biliary system was recently cleared to market by the US Food and Drug Administration.
Christiana Care Health System Interventional Radiology chief Mark Garcia said that the Supera’s high radial strength is suited for treating biliary strictures. Because of its characteristics, I’ve deployed a number of Supera stents over the past year.
"This new delivery system worked flawlessly and the driving mechanism was smooth and very responsive and the post-procedure images revealed optimal stent placement with excellent cholangiographic results and patency. I’m very pleased with the result," Garcia said.